全文获取类型
收费全文 | 125622篇 |
免费 | 8493篇 |
国内免费 | 451篇 |
专业分类
耳鼻咽喉 | 1451篇 |
儿科学 | 3471篇 |
妇产科学 | 2440篇 |
基础医学 | 15383篇 |
口腔科学 | 2298篇 |
临床医学 | 14011篇 |
内科学 | 24550篇 |
皮肤病学 | 1645篇 |
神经病学 | 12510篇 |
特种医学 | 4838篇 |
外国民族医学 | 3篇 |
外科学 | 19696篇 |
综合类 | 1703篇 |
一般理论 | 177篇 |
预防医学 | 11074篇 |
眼科学 | 2548篇 |
药学 | 8473篇 |
2篇 | |
中国医学 | 137篇 |
肿瘤学 | 8156篇 |
出版年
2023年 | 581篇 |
2022年 | 466篇 |
2021年 | 2128篇 |
2020年 | 1540篇 |
2019年 | 2410篇 |
2018年 | 2927篇 |
2017年 | 2095篇 |
2016年 | 2301篇 |
2015年 | 2642篇 |
2014年 | 4019篇 |
2013年 | 5583篇 |
2012年 | 8638篇 |
2011年 | 9201篇 |
2010年 | 5283篇 |
2009年 | 4648篇 |
2008年 | 8214篇 |
2007年 | 8631篇 |
2006年 | 8352篇 |
2005年 | 7990篇 |
2004年 | 7790篇 |
2003年 | 7005篇 |
2002年 | 6587篇 |
2001年 | 1772篇 |
2000年 | 1487篇 |
1999年 | 1575篇 |
1998年 | 1282篇 |
1997年 | 983篇 |
1996年 | 823篇 |
1995年 | 886篇 |
1994年 | 772篇 |
1993年 | 745篇 |
1992年 | 1111篇 |
1991年 | 1093篇 |
1990年 | 968篇 |
1989年 | 887篇 |
1988年 | 856篇 |
1987年 | 823篇 |
1986年 | 787篇 |
1985年 | 810篇 |
1984年 | 715篇 |
1983年 | 657篇 |
1982年 | 590篇 |
1981年 | 517篇 |
1980年 | 436篇 |
1979年 | 510篇 |
1978年 | 424篇 |
1977年 | 364篇 |
1976年 | 312篇 |
1974年 | 354篇 |
1973年 | 329篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Kinase alterations are increasingly recognised as oncogenic drivers in mesenchymal tumours. Infantile fibrosarcoma and the related renal tumour, congenital mesoblastic nephroma, were among the first solid tumours shown to harbour recurrent tyrosine kinase fusions, with the canonical ETV6::NTRK3 fusion identified more than 20 years ago. Although targeted testing has long been used in diagnosis, the advent of more robust sequencing techniques has driven the discovery of kinase alterations in an array of mesenchymal tumours. As our ability to identify these genetic alterations has improved, as has our recognition and understanding of the tumours that harbour these alterations. Specifically, this study will focus upon mesenchymal tumours harbouring NTRK or other kinase alterations, including tumours with an infantile fibrosarcoma-like appearance, spindle cell tumours resembling lipofibromatosis or peripheral nerve sheath tumours and those occurring in adults with a fibrosarcoma-like appearance. As publications describing the histology of these tumours increase so, too, do the variety kinase alterations reported, now including NTRK1/2/3, RET, MET, RAF1, BRAF, ALK, EGFR and ABL1 fusions or alterations. To date, these tumours appear locally aggressive and rarely metastatic, without a clear link between traditional features used in histological grading (e.g. mitotic activity, necrosis) and outcome. However, most of these tumours are amenable to new targeted therapies, making their recognition of both diagnostic and therapeutic import. The goal of this study is to review the clinicopathological features of tumours with NTRK and other tyrosine kinase alterations, discuss the most common differential diagnoses and provide recommendations for molecular confirmation with associated treatment implications. 相似文献
3.
Mursheda Begum Grant Lewison Xiang Wang Philip D. Dunne Tim Maughan Richard Sullivan Mark Lawler 《International journal of cancer. Journal international du cancer》2023,152(3):470-479
The purpose of this study was to provide an evidence base for colorectal cancer research activity that might influence policy, mainly at the national level. Improvements in healthcare delivery have lengthened life expectancy, but within a situation of increased cancer incidence. The disease burden of CRC has risen significantly, particularly in Africa, Asia and Latin America. Research is key to its control and reduction, but few studies have delineated the volume and funding of global research on CRC. We identified research papers in the Web of Science (WoS) from 2007 to 2021, and determined the contributions of the leading countries, the research domains studied, and their sources of funding. We identified 62 716 papers, representing 5.7% of all cancer papers. This percentage was somewhat disproportionate to the disease burden (7.7% in 2015), especially in Eastern Europe. International collaboration increased over the time period in almost all countries except in China. Genetics, surgery and prognosis were the leading research domains. However, research on palliative care and quality-of-life in CRC was lacking. In Western Europe, the main funding source was the charity sector, particularly in the UK, but in most other countries government played the leading role, especially in China and the USA. There was little support from industry. Several Asian countries provided minimal contestable funding, which may have reduced the impact of their CRC research. Certain countries must perform more CRC research overall, especially in domains such as screening, palliative care and quality-of-life. The private-non-profit sector should be an alternative source of support. 相似文献
4.
5.
Knox Joseph A. Kumar Vishal Conrad Miles B. Nanavati Sujal Moore Teri Wilson Mark 《Emergency radiology》2022,29(3):605-609
Emergency Radiology - Access to multi-detector computed tomography (MDCT) scanning for interventional procedures can prove to be logistically challenging as resources are often in different areas... 相似文献
6.
Thomas Fuchs-Buder Sorin J. Brull Malin Jonsson Fagerlund J. Ross Renew Guy Cammu Glenn S. Murphy Michiel Warlé Matias Vested Béla Fülesdi Reka Nemes Malachy O. Columb Daniela Damian Peter J. Davis Hajime Iwasaki Lars I. Eriksson 《Acta anaesthesiologica Scandinavica》2023,67(8):994-1017
The set of guidelines for good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents was developed following an international consensus conference in Copenhagen in 1996 (Viby-Mogensen et al., Acta Anaesthesiol Scand 1996, 40 , 59–74); the guidelines were later revised and updated following the second consensus conference in Stockholm in 2005 (Fuchs-Buder et al., Acta Anaesthesiol Scand 2007, 51 , 789–808). In view of new devices and further development of monitoring technologies that emerged since then, (e.g., electromyography, three-dimensional acceleromyography, kinemyography) as well as novel compounds (e.g., sugammadex) a review and update of these recommendations became necessary. The intent of these revised guidelines is to continue to help clinical researchers to conduct high-quality work and advance the field by enhancing the standards, consistency, and comparability of clinical studies. There is growing awareness of the importance of consensus-based reporting standards in clinical trials and observational studies. Such global initiatives are necessary in order to minimize heterogeneous and inadequate data reporting and to improve clarity and comparability between different studies and study cohorts. Variations in definitions of endpoints or outcome variables can introduce confusion and difficulties in interpretation of data, but more importantly, it may preclude building of an adequate body of evidence to achieve reliable conclusions and recommendations. Clinical research in neuromuscular pharmacology and physiology is no exception. 相似文献
7.
8.
9.
Joseph Wheatley Zhengyang Liu Joel Loth Mark P. Plummer Jahan C. Penny-Dimri Reny Segal Julian Smith Luke A. Perry 《Acta anaesthesiologica Scandinavica》2023,67(2):131-141